WHEN EVERYTHING YOU DO IS WRONG:
RESUSCITATION IN RV FAILURE
Disclosures and Disclaimers
• No financial or other conflicts of interest
• Views/opinions are entirely my own and may not be
reflective of my employers.
• Any specific brands or products mentioned are
illustrative and/or for clarity and not intended as
product endorsement.
• This presentation is not a substitute for sound
medical judgment or common sense. Know and
follow your local protocols. Consult medical control
as indicated.
Objectives
• Describe the basic cardiovascular anatomy and
physiology
• Differentiate right-sided cardiac physiology from
left-sided physiology
• Describe the pathophysiology of acute right
ventricular failure
• Identify common interventions or pharmacologic
treatments that could be detrimental in the setting of
acute right ventricular failure.
• Describe an appropriate treatment regimen for the
Interfacility transfer
Community ER to Tertiary ICU
Acute pulmonary embolism
Anxious, dyspneic, distressed
HR 120s RR 30s SBP 100
Unable to obtain reliable SpO
2
Initial Management
• IV Fluid bolus
• RSI induction
• Intubation
• Mechanical ventialtion
..
Resuscitation
• Additional crystalloid bolus
• Push dose phenylephrine
• Rapid norepi titration
Deteriorated into cardiac arrest
..
Discussion
Epidemiology
True prevalence difficult to know
• Acute vs chronic
• Failure vs dysfunction
Cardiol Clin 2013;31:545
pHTN
LV Fx
Leading cause of RV dysfunction is pulmonary hypertension
Leading cause of pulmonary hypertension is LV dysfunction
Circulation 2018;137:e578
Circulation 2018;137:e578
Circulation 2018;137:e578
Estimated prevalence of RV dysfunction
• Up to 48% of HFrEF cases (LV dysfunction)
• Approx 16% of ischemic cardiomyopathies
• Approx 60% of nonischemic cardiomyopathies
• Around 25-60% of pulmonary emboli
Cardiol Clin 2012;30:167 Cardiol Clin 2013;31:545 Arq Bras Cardiol 2000;75(2):111
2
mm
5
mm
RV Differences
• Thinner wall
• “C” shaped
• Low–pressure system
RV and LV encased within fairly “rigid” pericardium
5
20
5
20
10
10
10
120
10
Cardiol Clin 2012;30:167
Cardiol Clin 2012;30:167 Cardiol Clin 2013;31:545
20
5
20
10
120
10
120
80
LV Syst: 120 - 120 =
X
LV Dias: 80 - 10 =
RV Syst: 120 - 20 =
RV Dias: 80 - 5 =
Ciculation 1954;9:706
Preload
Str
oke
V
olume
RV
LV
Normal
Ischemic
RV
LV
Afterload
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
Str
oke
V
J Clin Invest 1966;45:399
PO
2
Pulm
V
asc
Reistance
pH 7.4
pH 7.3
pH 7.2
pH 7.1
RV
DEATH
SPIRAL
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
RV Ischemia
↓ LV preload
RV Dilation
↓ Cardiac Output
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
↓ MAP
↓ pH (acidosis)
Systemic hypoxia
and/or hypercarbia
↑ PVR
↑ RV afterload
RV DEATH SPIRAL
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
↑ RV pressure
↑ RV volume
Cardiol Clin 2012;30:167 Cardiol Clin 2013;31:54520
5
20
10
120
10
120
80
LV Syst: 120 - 120 =
X
LV Dias: 80 - 10 =
RV Syst: 120 - 20 =
RV Dias: 80 - 5 =
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
RV Ischemia
Ciculation 1954;9:706
Preload
Str
oke
V
olume
RV
Normal
Ischemic
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
RV Ischemia
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
RV Ischemia
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
RV Dilation
Cardiol Clin 2012;30:167 Arq Bras Cardiol 2000;75(2):111
Cardiol Clin 2012;30:167 Arq Bras Cardiol 2000;75(2):111
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
RV Ischemia
↓ LV preload
RV Dilation
↓ Cardiac Output
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
↓ MAP
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
RV Ischemia
↓ LV preload
RV Dilation
↓ Cardiac Output
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
↓ MAP
↓ pH (acidosis)
Systemic hypoxia
and/or hypercarbia
J Clin Invest 1966;45:399
PO
2
Pulm
V
asc
Reistance
pH 7.4
pH 7.3
pH 7.2
pH 7.1
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
RV Ischemia
↓ LV preload
RV Dilation
↓ Cardiac Output
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
↓ MAP
↓ pH (acidosis)
Systemic hypoxia
and/or hypercarbia
↑ PVR
↑ RV afterload
RV
Afterload
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
Str
oke
V
Chest 2005;128:1836 Crit Care 2010; 14:R169
Ann Am Thorac Soc 2014;11:811 Circulation 2018;137:e578
RV Dysfunction
RV Ischemia
↓ LV preload
RV Dilation
↓ Cardiac Output
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
↓ MAP
↓ pH (acidosis)
Systemic hypoxia
and/or hypercarbia
↑ PVR
↑ RV afterload
RV Dysfunction
RV Ischemia
↓ LV preload
RV Dilation
↓ Cardiac Output
↑ RV pressure
↑ RV volume
↑ RV wall tension
↓ RCA perfusion
↓ MAP
↓ pH (acidosis)
Systemic hypoxia
and/or hypercarbia
↑ PVR
↑ RV afterload
IV Fluids:
↑ RV preload
Pressors:
↑ SVR
Positive-pressure
ventilation
RSI
Pressors:
↑ SVR and PVR
Crit Care 2010; 14:R169
Intensive Care Med 2019;45:1503
α
1
β
1
β
2
V
1
/V
2
D
1
/D
2
SVR/
MAP
HR/
CO
Norepinephrine
+++
++
-
-
-
Epinephrine
+++
+++
++
-
-
Phenylephrine
+++
-
-
-
-
Vasopressin
-
-
-
+++
-
Dopamine
+*
++*
+*
-
+++
Dobutamine
-
+++
-
-
-
PVR
PVR/
SVR*
/
/
/
/
Oxygen
Nitric oxide
Epoprostenol
Nitroglycerin
/
/
Crit Care 2010; 14:R169 Pharmacotherapy 2010;30:728 Nitric Oxide 2019;84:60Intensive Care Med 2019;45:1503